MedPath

BAY-2328065

Generic Name
BAY-2328065

A Trial to Learn What Happens to Different Medicinal Forms of BAY2328065 When They Enter the Body and How Safe They Are in Healthy Male and Female Participants

Phase 1
Completed
Conditions
Endometriosis
Interventions
Drug: Placebo
First Posted Date
2021-04-20
Last Posted Date
2022-06-01
Lead Sponsor
Bayer
Target Recruit Count
31
Registration Number
NCT04851483
Locations
🇩🇪

CRS Clinical-Research-Services Mannheim GmbH, Mannheim, Baden-Württemberg, Germany

BAY2328065 Single Dose Escalation, Safety and Tolerability, Pharmacokinetics, Relative Bioavailability, Food Effect

Phase 1
Completed
Conditions
Endometriosis
Interventions
Drug: Placebo
First Posted Date
2018-02-09
Last Posted Date
2024-02-29
Lead Sponsor
Bayer
Target Recruit Count
72
Registration Number
NCT03427788
Locations
🇩🇪

CRS Clinical Research Services Berlin GmbH, Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath